Compare, Analyse IPCA Labs with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs ACTAVIS (US) - Comparison Results

IPCA LABS     Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 IPCA LABS   ACTAVIS
EQUITY SHARE DATA
    IPCA LABS
Mar-19
ACTAVIS
Dec-18
IPCA LABS/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1,04214,478-   
Low Rs5909,712-   
Sales per share (Unadj.) Rs298.63,551.4-  
Earnings per share (Unadj.) Rs35.0-1,143.9-  
Cash flow per share (Unadj.) Rs49.4374.2-  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs247.114,647.7-  
Shares outstanding (eoy) m126.35332.60-   
Bonus/Rights/Conversions ESOS--  
Price / Sales ratio x2.73.4 80.2%   
Avg P/E ratio x23.3-10.6 -220.5%  
P/CF ratio (eoy) x16.532.3 51.1%  
Price / Book Value ratio x3.30.8 399.9%  
Dividend payout %8.60-   
Avg Mkt Cap Rs m103,1084,022,682 2.6%   
No. of employees `00013.416.9 79.5%   
Total wages/salary Rs m7,8740-   
Avg. sales/employee Rs Th2,807.069,892.5 4.0%   
Avg. wages/employee Rs Th585.80-   
Avg. net profit/employee Rs Th329.0-22,512.4 -1.5%   
INCOME DATA
Net Sales Rs m37,7321,181,183 3.2%  
Other income Rs m57722,588 2.6%   
Total revenues Rs m38,3091,203,771 3.2%   
Gross profit Rs m6,90130,953 22.3%  
Depreciation Rs m1,824504,930 0.4%   
Interest Rs m18968,161 0.3%   
Profit before tax Rs m5,465-519,550 -1.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0132,506 0.0%   
Tax Rs m1,042-6,584 -15.8%   
Profit after tax Rs m4,422-380,460 -1.2%  
Gross profit margin %18.32.6 697.9%  
Effective tax rate %19.11.3 1,505.2%   
Net profit margin %11.7-32.2 -36.4%  
BALANCE SHEET DATA
Current assets Rs m23,778484,460 4.9%   
Current liabilities Rs m10,975428,569 2.6%   
Net working cap to sales %33.94.7 717.1%  
Current ratio x2.21.1 191.7%  
Inventory Days Days10420 529.8%  
Debtors Days Days6666 99.4%  
Net fixed assets Rs m20,368133,703 15.2%   
Share capital Rs m2530-   
"Free" reserves Rs m30,9710-   
Net worth Rs m31,2244,871,829 0.6%   
Long term debt Rs m1,4091,715,548 0.1%   
Total assets Rs m45,5077,615,778 0.6%  
Interest coverage x30.0-6.6 -452.4%   
Debt to equity ratio x00.4 12.8%  
Sales to assets ratio x0.80.2 534.6%   
Return on assets %10.1-4.1 -247.1%  
Return on equity %14.2-7.8 -181.4%  
Return on capital %17.3-4.8 -357.9%  
Exports to sales %45.90-   
Imports to sales %16.60-   
Net fx Rs m11,0420-   
CASH FLOW
From Operations Rs m4,923421,992 1.2%  
From Investments Rs m-1,563231,830 -0.7%  
From Financial Activity Rs m-1,832-724,265 0.3%  
Net Cashflow Rs m1,528-70,091 -2.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 74.82 Rs / USD

Compare IPCA LABS With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare IPCA LABS With: GSK PHARMA  FRESENIUS KABI ONCO.  ALKEM LABORATORIES  FDC  PIRAMAL ENTERPRISES  



Today's Market

Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views On News

IPCA LABS Announces Quarterly Results (3QFY21); Net Profit Up 32.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, IPCA LABS has posted a net profit of Rs 3 bn (up 32.2% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY21); Net Profit Up 243.5% (Quarterly Result Update)

Sep 29, 2020 | Updated on Sep 29, 2020

For the quarter ended June 2020, IPCA LABS has posted a net profit of Rs 5 bn (up 243.5% YoY). Sales on the other hand came in at Rs 15 bn (up 46.9% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave (Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

An India Revival Stock I'm Bullish On... (Profit Hunter)

Apr 9, 2021

This could take India to the position of 3rd largest economy.

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Unique Sector for Short-Term Profits (Fast Profits Daily)

Apr 12, 2021

This ignored sector could deliver big short-term profits.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

IPCA LABS SHARE PRICE


Apr 16, 2021 (Close)

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON IPCA LABS

IPCA LABS 5-YR ANALYSIS

COMPARE IPCA LABS WITH

FEATURED VIDEOS

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

Nifty: Bear Trap?

More Featured Videos

MARKET STATS